Ingredient in common cough medicine may aid diabetes treatment
the ONA take:
An ingredient found in common cough medicine may be able to aid in the treatment of patients with type 2 diabetes, according to a study published in Nature Medicine.
Researchers examined the effects of dextromethorphan, an active ingredient in cough suppressants, in order to build on prior research which showed that it had potential impact on receptor cells in the pancreas. Initially they hypothesized that the compound would actually worsen insulin production.
Instead, the team found that the ingredient caused the receptor cells to boost insulin production in the pancreas.
They tested the effect with a single-dose trial in 20 male patients with diabetes and found that the men “showed enhanced serum insulin concentrations and glucose tolerance.”
Findings, however, are still preliminary, and the researchers advise against diabetics self-medicating with cough medicine. Future testing was encouraged by the team.
An ingredient found in common cough medicine may be able to aid in the treatment of patients with type 2 diabetes.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- A Witness to Letting Go: Nursing Care at the End of Life
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Intervention Improves Breast Cancer Survivors' Memory Contentment
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Patients With Head and Neck Cancer Have Greater Chance of Being Prescribed Opioids
- Medical Terms in Patient Education: Using the Confusing to Explain the Complicated
- Bedside Assessment Tool Improves Worst Pain in Patients With Cancer
- Androgen-Deprivation Therapy for Prostate Cancer May Cause Nocturia, Sleep Disturbance
- USPSTF Rates Ovarian Cancer Screening a D for Asymptomatic, Low-Risk Women
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|